Nisa Investment Advisors’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.4K | Sell |
2,748
-127
| -4% | -$573 | ﹤0.01% | 2166 |
|
2025
Q1 | $13.3K | Buy |
2,875
+37
| +1% | +$172 | ﹤0.01% | 2022 |
|
2024
Q4 | $19.7K | Buy |
2,838
+79
| +3% | +$548 | ﹤0.01% | 1939 |
|
2024
Q3 | $14.6K | Buy |
2,759
+40
| +1% | +$212 | ﹤0.01% | 2012 |
|
2024
Q2 | $10.2K | Buy |
2,719
+2,706
| +20,815% | +$10.1K | ﹤0.01% | 2148 |
|
2024
Q1 | $92 | Buy |
+13
| New | +$92 | ﹤0.01% | 2719 |
|
2023
Q4 | – | Sell |
-1,170
| Closed | -$5.6K | – | 2679 |
|
2023
Q3 | $5.6K | Buy |
+1,170
| New | +$5.6K | ﹤0.01% | 2271 |
|
2023
Q2 | – | Sell |
-2,190
| Closed | -$17K | – | 2828 |
|
2023
Q1 | $17K | Buy |
2,190
+168
| +8% | +$1.3K | ﹤0.01% | 2054 |
|
2022
Q4 | $15K | Buy |
2,022
+22
| +1% | +$163 | ﹤0.01% | 2120 |
|
2022
Q3 | $18K | Hold |
2,000
| – | – | ﹤0.01% | 2076 |
|
2022
Q2 | $19K | Buy |
+2,000
| New | +$19K | ﹤0.01% | 2057 |
|